The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,432.00
Bid: 1,438.00
Ask: 1,440.00
Change: 5.00 (0.35%)
Spread: 2.00 (0.139%)
Open: 1,425.00
High: 1,443.00
Low: 1,423.00
Prev. Close: 1,427.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Indivior Surges 25% On Upgraded Guidance

Thu, 11th Jul 2019 10:32

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Barratt Developments, up 3.5%, Taylor Wimpey, up 1.7%, Persimmon, up 1.3%, Berkeley Group, up 1.2%. Shares in the housebuilders were higher following the latest results from the Royal Institution of Chartered Surveyors UK Residential Market Survey. Appetite for buying a home has picked up for the first time in nearly three years, surveyors have reported. An overall net balance of 10% more surveyors saw an increase rather than a decrease in interest from new buyers in June, according to RICS. There are also signs of a more stable trend in the supply of homes coming on the market, RICS said. For the first time in a year, surveyors are seeing positive growth in properties being listed for sale. "Investors raced to snap up shares in housebuilders after the latest RICS survey showed some signs of recovery in the housing market. Although it is too early to call a bounce-back in the property market based on one set of data, the news does offer a glimmer of hope for investors in housebuilding stocks," AJ Bell's Russ Mould said.----------Reckitt Benckiser, up 2.8%. The consumer goods firm said it agreed with the US Department of Justice and the Federal Trade Commission to resolve an investigation into the sales and marketing of Suboxone Film by former prescription pharmaceuticals arm Indivior. In September 2016, 35 US states and the District of Columbia filed a civil complaint against Indivior in relation to its ongoing legal privilege dispute with the US Federal Trade Commission. Since then, the commission has been investigating whether Indivior, then owned by former parent Reckitt, tried to prevent generic competition for its Suboxone Film opioid addiction treatment. The firm on Thursday said it will pay up to USD1.4 billion to fully resolve all federal investigations into Reckitt in connection with the Indivior indictment and claims relating to state Medicaid programs for those states choosing to participate in the settlement. ----------FTSE 100 - LOSERS----------Halma, down 1.0%. The stock went ex-dividend meaning new buyers no longer qualify for the latest payout. ----------Experian, down 0.8%. Goldman Sachs cut the credit checking agency to Neutral from Buy. ----------FTSE 250 - WINNERS----------Diploma, up 5.5%. The technical products and services firm announced the GBP56.0 million takeover of a gasket and fluid-sealing products maker. Virginia Sealing Products Inc specialises in customers who process and transport hazardous materials but also operates in markets such as power generation, pulp & paper, and marine. Diploma is paying GBP56.0 million in cash upfront, but it may also pay a further GBP8.0 million if VSP meets various operating profit targets. The deal will be funded from existing cash and new debt, but Diploma said it "will continue to maintain a strong balance sheet". ----------John Wood, up 3.8%. Bernstein promoted the oilfield services firm to its Top Pick within its oil sector coverage. ----------FTSE 250 - LOSERS----------Telecom Plus, down 1.0%. The stock went ex-dividend. ----------OTHER MAIN MARKET AND AIM - WINNERS----------Indivior, up 25%. The pharmaceuticals firm revised its expectations for 2019 net revenue and net income higher following a stronger-than-expected first half. Indivior highlighted that the primary driver of growth has been the market share outperformance of Suboxone Film. Indivior said it now expects net revenue for 2019 to be in a range of USD670 million to USD720 million and net income in a range of USD80 million to USD130 million. The company had previously expected net revenue to come in between USD525 million and USD575 million, and net income was not seen higher than USD10 million. In 2018, Indivior delivered net revenue of USD1.00 billion and net income of USD275 million. ----------Sosandar, up 12% at 16.25p. The online women's fashion retailer said it has raised GBP7 million at a premium to push forward with future growth. Sosandar placed approximately 46.7 million shares at 15 pence per share. Sosandar said the placing price represented a 3.4% premium to Thursday's closing price. The placing comprises of a firm placing of 22.7 million shares with a further placing of 24.0 million shares, conditional on shareholder approval. Sosandar said the placing was needed to raise additional equity to "help support and accelerate further growth".----------OTHER MAIN MARKET AND AIM - LOSERS----------Tekcapital, down 27% at 8.25p. The investment company focused on university-developed technology said it intends to raise GBP750,000 through a share placing to fund investment in key activities and to further develop and progress with the commercialisation of its portfolio of intellectual property. The AIM-listed firm said it will issue 9.4 million shares at a price of 8 pence each. Following the admission, Tekcapital will have 63.7 million shares overall. A significant amount of the placing will be utilised to expand Tekcapital's commercialisation of its investment portfolio of businesses, the company highlighted.----------

More News
3 May 2024 09:14

LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
2 May 2024 13:48

UK shareholder meetings calendar - next 7 days

Friday 3 May 
Ashoka India Equity Investment Trust PLCGM re share issue
HSBC Holdings PLCAGM
Intercontinental Hotels Group PLCAGM
Mondi PLCAGM
More Acquisitions PLCAGM
Monday 6 May 
no events scheduled 
Tuesday 7 May 
Caledonia Mining Corp PLCAGM
CPPGroup PLCAGM
Just Group PLCAGM
Macfarlane Group PLC AGM
Plus500 LtdAGM
Supernova Digital Assets PLCAGM
Wednesday 8 May 
Airea PLCAGM
Antofagasta PLCAGM
Aston Martin Lagonda Global Holdings PLCAGM
Deltex Medical Group PLCAGM
Direct Line Insurance Group PLCAGM
Fidelity European Trust PLCAGM
Haleon PLCAGM
Jardine Matheson PLCAGM
JZ Capital Partners LtdEGM re investing in a secondary fund
Oscillate PLCAGM
Pershing Square Holdings LtdAGM
Rentokil Initial PLCAGM
WPP PLCAGM
Thursday 9 May 
Ascential PLCAGM
BAE Systems PLCAGM
Balfour Beatty PLCAGM
Barclays PLCAGM
CAB Payments Holdings PLCAGM
Catenai PLCGM re convertible loan note
Clarkson PLCAGM
FBD Holdings PLCAGM
Genel Energy plcAGM
Gym Group PLCAGM
Harbour Energy PLCAGM
Hiscox LtdAGM
IMI PLCAGM
Inchcape PLCAGM
Indivior PLCAGM
John Wood Group PLCAGM
Jupiter Fund Management PLCAGM
Logistics Development Group PLCAGM
Man Group PLCAGM
Morgan Advanced Materials PLCAGM
OSB Group PLCAGM
Public Policy Holding Co IncAGM
Rathbones Group PLCAGM
RM PLCAGM
Spire Healthcare Group PLCAGM
Synthomer PLCAGM
Uniphar PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
25 Apr 2024 09:23

Indivior shares down despite profit boost on planned shift to New York

(Alliance News) - Indivior PLC on Thursday saw its shares fall despite reporting a quarterly uptick in profit, as it announced plans to switch its listing to New York.

Read more
25 Apr 2024 08:56

Indivior reports first-quarter growth, confirms plans to shift main listing

(Sharecast News) - Addiction treatment specialist Indivior reported double-digit net revenue growth for the first quarter on Thursday, with total net revenue rising 12% year-on-year to $284m, as it confirmed its intention to shift its primary listing to the United States.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
18 Mar 2024 14:28

IN BRIEF: Indivior CCO Richard Simkin sells GBP1 million in shares

Indivior PLC - Chesterfield, Virginia-headquartered pharmaceutical maker - Chief Commercial Officer Richard Simkin sells 61,285 shares at GBP16.30 each, worth GBP998,946, in London on Thursday. Following this transaction, Simkin is now interested in 117,590 shares.

Read more
12 Mar 2024 09:29

LONDON BROKER RATINGS: UBS cuts abrdn price target but ups Darktrace's

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
8 Mar 2024 20:04

IN BRIEF: Indivior chief commercial officer sells GBP500,000 in shares

Indivior PLC - Chesterfield, Virginia-headquartered pharmaceutical maker - Chief Commercial Officer Richard Simkin sells 30,000 shares on Wednesday at average GBP17.22 each, for a total of GBP516,600.

Read more
7 Mar 2024 12:39

DIRECTOR DEALINGS: Oxford Nanopore Technologies top team buys shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and Thursday and not separately reported by Alliance News:

Read more
29 Feb 2024 19:10

Indivior says US court draws line on multi-district Suboxone case

(Alliance News) - Indivior PLC on Thursday said it received final court approval for a settlement of a multi-district Suboxone litigation case.

Read more
29 Feb 2024 09:47

Indivior receives settlement approval for antitrust litigation

(Sharecast News) - Pharmaceuticals business Indivior has received final court approval for a landmark settlement in an antitrust multi-district litigation with the direct purchaser class.

Read more
22 Feb 2024 16:53

LONDON MARKET CLOSE: European stocks boosted by ECB and Fed minutes

(Alliance News) - Stock prices in Europe closed higher on Thursday, on the back of minutes from the latest European Central Bank and US Federal Reserve meetings.

Read more
22 Feb 2024 16:26

London close: Stocks rise amid raft of solid earnings

(Sharecast News) - London's stock markets finished in positive territory on Thursday, bolstered by upbeat performances from US AI chipmaker Nvidia and engine manufacturer Rolls-Royce.

Read more
22 Feb 2024 11:44

LONDON MARKET MIDDAY: Stocks boosted as UK recession "already" over

(Alliance News) - Stock prices in London were higher at midday Thursday, with the latest UK purchasing managers' index data indicating that the UK recession is "already" over.

Read more
22 Feb 2024 09:55

TOP NEWS: Indivior swings to profit as eyes primary listing move to US

(Alliance News) - Shares in Indivior PLC rose on Thursday, after the company said that strong sales of its flagship Sublocade treatment had pushed its revenue to new heights, and it added that it will begin talks with shareholders to move its primary listing across the Atlantic.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.